Shriram Finance ka Focus: Operating Leverage aur Productivity Badhana
Shriram Finance abhi operating leverage aur branch-level productivity ko sudharne par dhyan de rahi hai. Isse company ko apne margins ko banaaye rakhne mein madad milegi. Company ka plan hai ki woh apne underwriting model ko decentralize kare, matlab har branch ko loan dene ke decision mein zyada power mile.
900+ Branches Mein Naya System
Yeh naya system agle do-teen saalon mein 900 se zyada branches mein lagoo kiya jaayega. Isse loan dene ke process ko aur bhi behtar banaya ja sakega aur MSME (Micro, Small & Medium Enterprises) sector mein zyada logo tak pahucha ja sakega.
NDTV Profit ki Research Report
NDTV Profit ke special research section mein India ke top brokerages, asset managers aur research agencies se quality aur in-depth equity aur economy research reports ikattha kiye jaate hain. In reports se NDTV Profit ke subscribers ko companies, sectors aur economy ki samajh badhane ka mauka milta hai.
Nirmal Bang ki Report
Nirmal Bang ne Shriram Finance Ltd. ke management ke saath ek meeting ki. Management ka target hai ki FY26 tak ROA/ROE lagbhag 3.2%/17% ho. Medium term mein AUM (Assets Under Management) mein lagbhag 15-20% ki growth ki ummeed hai. Margin mein sudhar ki ummeed hai kyunki Shriram City Union Finance book se exposure kam kiya ja raha hai. Gold loan book mein strong demand aur operational discipline ke saath 18-20% CAGR ki ummeed hai.
Credit Cost aur Future Plans
FY25 mein credit cost 2.1% raha, jo company ke internal estimates ke hisab se tha. Medium term mein credit cost mein 15-20bps ki kami aane ki ummeed hai. Company ka focus operating leverage aur branch-level productivity ko sudharne par bana rahega. Nirmal Bang ne Rs 689 ka target price maintain kiya hai aur stock par apni ‘Hold’ rating ko bhi banaye rakha hai.
Sun Pharma Shares: Nirmal Bang ki ‘Buy’ Rating
Nirmal Bang ne Sun Pharma shares ko ‘Buy’ rating di hai. Unka kehna hai ki India aur specialty growth ko drive karenge.
